Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Letrozole for ER+ DCIS
NCT01439711Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Feb 2012
- Primary completion
- Aug 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of letrozole in ductal carcinoma in situ (DCIS), sponsored by Cancer and Leukemia Group B. Started Feb 2012; status: completed.
02
Drugs
letrozole
03
Conditions
ductal carcinoma in situ (DCIS)
Beyond the preview
Go deeper on NCT01439711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01439711.